3rd Quarter - Report

WASHINGTON HEALTH STRATEGIES GROUP for ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

21st Century Cures, Conduct of Clinical Trials, FDA, NIH, R&D Tax Credit, Corporate Tax Reform, Drug Safety, Innovation for Healthier Americans

LobbyistCovered position, as disclosed
SABAH BHATNAGAR New —
JOHN LEWIS —
DOUGLAS PEDDICORD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.